Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693693 · ClinicalTrials.gov registry record · Phase 4
Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis
A Phase 4 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT00693693 is a Phase 4 study that has completed, run by Wake Forest University. The registered enrollment target is 26 participants.
The verdict
NCT00693693, a Phase 4 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this research study is to better understand adherence to Locoid when people use it to treat atopic dermatitis.
Interventions
- DRUG hydrocortisone 17-butyrate 0.1% Cream preparation
- DRUG hydrocortisone 17-butyrate 0.1% Ointment preparation
- DRUG hydrocortisone 17-butyrate 0.1% Lipocream preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00693693
The ClinicalTrials.gov registry entry for NCT00693693 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which hydrocortisone 17-butyrate 0.1% Cream preparation is the first listed.
NCT00693693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00693693 about?
NCT00693693 is a clinical study titled "Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis". The purpose of this research study is to better understand adherence to Locoid when people use it to treat atopic dermatitis.
What is the current status of trial NCT00693693?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2006-11. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00693693?
The interventions under investigation include: hydrocortisone 17-butyrate 0.1% Cream preparation (DRUG), hydrocortisone 17-butyrate 0.1% Ointment preparation (DRUG), hydrocortisone 17-butyrate 0.1% Lipocream preparation (DRUG).
Who is sponsoring clinical trial NCT00693693?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.